CIK 0001053369
- Non-accelerated filer
- Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 223542636
- Phone
- +1 201-750-2646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $25,980
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$25,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-04-18 | EPIC PHARMA LLC 10% owner | Other disposition | −24,281,850 | $0.04 | $896K | 36,351,819 |
| 2012-04-18 | EPIC INVESTMENTS, LLC 10% owner | Other disposition | −24,281,850 | $0.04 | $896K | 36,351,819 |
| 2012-03-27 | POTTI RAM Director | Sale | −735,000 | $0.09 | $66K | 60,865,302 |
| 2012-03-27 | NIGALAYE ASHOK G Chief Financial Officer | Sale | −735,000 | $0.09 | $66K | 61,273,251 |
| 2012-03-27 | NARINE JEENARINE Director | Sale | −735,000 | $0.09 | $66K | 61,273,251 |
| 2012-03-27 | EPIC PHARMA LLC 10% owner | Sale | −735,000 | $0.09 | $66K | 60,633,669 |
| 2012-03-27 | EPIC PHARMA LLC 10% owner | Sale | −735,000 | $0.09 | $66K | 60,633,669 |
| 2012-03-26 | POTTI RAM Director | Sale | −225,000 | $0.09 | $21K | 61,600,302 |
| 2012-03-26 | NIGALAYE ASHOK G Chief Financial Officer | Sale | −225,000 | $0.09 | $21K | 62,008,251 |
| 2012-03-26 | NARINE JEENARINE Director | Sale | −225,000 | $0.09 | $21K | 62,008,251 |
| 2012-03-26 | EPIC PHARMA LLC 10% owner | Sale | −225,000 | $0.09 | $21K | 61,368,669 |
| 2012-03-26 | EPIC PHARMA LLC 10% owner | Sale | −225,000 | $0.09 | $21K | 61,368,669 |
| 2012-03-23 | Ward Carter Julian Chief Financial Officer, Sec. | Sale | −200,000 | $0.09 | $19K | 515,755 |
| 2012-03-23 | POTTI RAM Director | Sale | −1,765,000 | $0.10 | $169K | 61,825,302 |
| 2012-03-23 | NIGALAYE ASHOK G Chief Financial Officer | Sale | −1,765,000 | $0.10 | $169K | 62,233,251 |
| 2012-03-23 | NARINE JEENARINE Director | Sale | −1,765,000 | $0.10 | $169K | 62,233,251 |
| 2012-03-23 | EPIC PHARMA LLC 10% owner | Sale | −1,765,000 | $0.10 | $169K | 61,593,669 |
| 2012-03-23 | EPIC PHARMA LLC 10% owner | Sale | −1,765,000 | $0.10 | $169K | 61,593,669 |
| 2012-03-20 | POTTI RAM Director | Grant or award | +231,633 | $0.10 | $22K | 63,590,302 |
| 2012-03-20 | NIGALAYE ASHOK G Chief Scientific Officer | Grant or award | +231,633 | $0.10 | $22K | 63,998,251 |
Page 23 of 28 · 542 trades